View of Renal and Glycemic Outcomes with Linagliptin versus Vildagliptin as Add-On Therapy in Uncontrolled Type 2 Diabetes Mellitus: A Prospective Observational Study
Return to Article Details Renal and Glycemic Outcomes with Linagliptin versus Vildagliptin as Add-On Therapy in Uncontrolled Type 2 Diabetes Mellitus: A Prospective Observational Study Download Download PDF